A new landmark clinical trial from Standford Medicine shows that a drug lowers the risk of kidney failure by a third in people with Type 2 diabetes
The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the submission of a supplemental New Drug Application (sNDA) to the
The U.S. Food and Drug Administration (FDA) has approved a label update for AstraZeneca’s FARXIGA® (dapagliflozin) and XIGDUO® XR
Vitamin B supplements have a protective effect on kidney function in children and adolescents with Type 1 diabetes, according to new research. The
The kidneys are vital organs in the human body and are responsible for “cleaning” blood of waste and toxins. If you have diabetes and
Proper treatment and refraining from smoking can significantly reduce the risk of cardiovascular disease resulting from Type 2 diabetes, a new
Get a little dLife delivered to your inbox every week.
Leave this field empty if you’re human: